Squarepoint
PAHC icon

Squarepoint’s Phibro Animal Health PAHC Stock Holding History

Squarepoint’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Sell
42,977
-55,593
-56% -$2.65M ﹤0.01% 2051
2025
Q4 		$3.68M Sell
98,570
-5,302
-5% -$215K ﹤0.01% 1654
2025
Q3 		$4.2M Buy
103,872
+72,028
+226% +$2.38M ﹤0.01% 1569
2025
Q2 		$813K Buy
+31,844
New +$694K ﹤0.01% 2846
2024
Q3 		– Sell
-13,582
Closed -$228K – 4546
2024
Q2 		$228K Sell
13,582
-21,553
-61% -$346K ﹤0.01% 3583
2024
Q1 		$454K Sell
35,135
-26,285
-43% -$315K ﹤0.01% 3114
2023
Q4 		$711K Buy
+61,420
New +$693K ﹤0.01% 2757
2022
Q1 		– Sell
-11,795
Closed -$241K – 3340
2021
Q4 		$241K Buy
+11,795
New +$252K ﹤0.01% 2583
2021
Q1 		– Sell
-31,254
Closed -$607K – 3493
2020
Q4 		$607K Sell
31,254
-12,761
-29% -$235K ﹤0.01% 1663
2020
Q3 		$766K Buy
+44,015
New +$939K 0.01% 1141
2020
Q2 		– Sell
-14,237
Closed -$344K – 2444
2020
Q1 		$344K Sell
14,237
-34,443
-71% -$842K 0.01% 1235
2019
Q4 		$1.21M Buy
48,680
+20,124
+70% +$467K 0.01% 1224
2019
Q3 		$609K Sell
28,556
-8,521
-23% -$233K 0.01% 1514
2019
Q2 		$1.18M Buy
37,077
+10,173
+38% +$319K 0.01% 1164
2019
Q1 		$888K Sell
26,904
-564
-2% -$17.6K 0.01% 1166
2018
Q4 		$883K Buy
27,468
+11,493
+72% +$434K 0.01% 976
2018
Q3 		$685K Buy
+15,975
New +$755K 0.01% 1162
2018
Q2 		– Sell
-18,409
Closed -$731K – 1970
2018
Q1 		$731K Buy
18,409
+2,161
+13% +$80K 0.01% 934
2017
Q4 		$544K Sell
16,248
-2,398
-13% -$85.1K 0.01% 1158
2017
Q3 		$691K Buy
18,646
+3,928
+27% +$148K 0.01% 859
2017
Q2 		$545K Buy
+14,718
New +$480K 0.01% 920
2016
Q2 		– Sell
-8,510
Closed -$230K – 1287
2016
Q1 		$230K Buy
+8,510
New +$244K 0.02% 942

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Squarepoint's PAHC Position: Q1 2026 in Review

Squarepoint reduced its Phibro Animal Health (PAHC) stake by 56% in Q1 2026, selling an estimated $2.65M and leaving 42,977 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Squarepoint first reported a position in PAHC in Q1 2016 and has held it in 22 quarters since. The position peaked at $4.2M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Squarepoint held 42,977 shares of Phibro Animal Health worth $2.38M as of Q1 2026.
  • Squarepoint sold 55,593 Phibro Animal Health shares in Q1 2026, an estimated $2.65M.
  • Phibro Animal Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2051 holding.
  • Squarepoint first reported a position in Phibro Animal Health in Q1 2016 and has held it in 22 quarters since.
  • Squarepoint's Phibro Animal Health position peaked at $4.2M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.